Skip to main content

Advertisement

Log in

Rheumatoid factor false positivity in patients with ANCA-associated vasculitis not having medical conditions producing rheumatoid factor

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

We investigated the rate of rheumatoid factor (RF) false positivity at diagnosis and its influence on clinical and prognostic features and rheumatoid arthritis (RA) development during the follow-up in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) patients without RA or other medical conditions triggering RF false positivity. We reviewed the medical records of 128 AAV patients. We divided patients with AAV and each variant into two groups according to RF positivity and compared variables between the two groups. Odds ratio and cumulative relapse-free survival rate were obtained by multivariate logistic regression analysis and the Kaplan-Meier survival analysis, respectively. The mean age at diagnosis was 53.6 years and 41 patients were male. Of 128 AAV patients, 69 patients (53.9%) were classified as microscopic polyangiitis (MPA), 29 (22.7%) as granulomatosis with polyangiitis (GPA) and 30 (23.4%) as eosinophilic GPA (EGPA). The rate of RF false positivity was 39.1% in AAV patients. On univariate analysis, general, cutaneous and mucous and ocular manifestations and myeloperoxidase (MPO)-ANCA (or perinuclear (P)-ANCA) positivity were associated with RF false positivity in patients with AAV. On multivariate analysis, cutaneous manifestation was the only independent predictor of RF false positivity in EGPA patients. RF false positivity had no influence on cumulative relapse-free survival rate of AAV or RA development during the follow-up. RF false positivity rate was 39.1% in AAV patients and it was associated with cutaneous manifestation in EGPA patients at diagnosis, but not relapses of AAV or RA development during the follow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Sun J, Zhang Y, Liu L, Liu G (2014) Diagnostic accuracy of combined tests of anti cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis: a meta-analysis. Clin Exp Rheumatol 32(1):11–21

    PubMed  Google Scholar 

  2. Carson DA, Chen PP, Kipps TJ, Roudier J, Silverman GJ, Tighe H (1989) Regulation of rheumatoid factor synthesis. Clin Exp Rheumatol 7(Suppl 3):S69–S73

    PubMed  Google Scholar 

  3. Teitsson I (1988) IgA rheumatoid factor as predictor of disease activity. Scand J Rheumatol Suppl 75:233–237

    Article  PubMed  CAS  Google Scholar 

  4. Mariette X (2001) Lymphomas complicating Sjögren’s syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells. Ann Rheum Dis 60(11):1007–1010

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al (2013) 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65(1):1–11

    Article  PubMed  CAS  Google Scholar 

  6. Kallenberg CG (2014) The diagnosis and classification of microscopic polyangiitis. J Autoimmun 48-49:90–93

    Article  PubMed  CAS  Google Scholar 

  7. Greco A, De Virgilio A, Rizzo MI, Gallo A, Magliulo G, Fusconi M et al (2015) Microscopic polyangiitis: advances in diagnostic and therapeutic approaches. Autoimmun Rev 14(9):837–844

    Article  PubMed  CAS  Google Scholar 

  8. Falk RJ, Gross WL, Guillevin L, Hoffman G, Jayne DR, Jennette JC et al (2011) Granulomatosis with polyangiitis (Wegener’s): an alternative name for Wegener’s granulomatosis. Ann Rheum Dis 70(4):704

    Article  PubMed  Google Scholar 

  9. Greco A, Rizzo MI, De Virgilio A, Gallo A, Fusconi M, Ruoppolo G et al (2015) Churg-Strauss syndrome. Autoimmun Rev 14(4):341–348

    Article  PubMed  CAS  Google Scholar 

  10. Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W et al (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66(2):222–227

    Article  PubMed  Google Scholar 

  11. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33(8):1101–1107

    Article  PubMed  CAS  Google Scholar 

  12. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33(8):1094–1100

    Article  PubMed  CAS  Google Scholar 

  13. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69(9):1580–1588

    Article  PubMed  Google Scholar 

  14. Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S et al (2009) Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 68(12):1827–1832

    Article  PubMed  CAS  Google Scholar 

  15. Stone JH, Hoffman GS, Merkel PA, Min YI, Uhlfelder ML, Hellmann DB et al (2001) A disease-specific activity index for Wegener’s granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum 44(4):912–920

    Article  PubMed  CAS  Google Scholar 

  16. Shim CN, Hwang JW, Lee J, Koh EM, Cha HS, Ahn JK (2012) Prevalence of rheumatoid factor and parameters associated with rheumatoid factor positivity in Korean health screening subjects and subjects with hepatitis B surface antigen. Mod Rheumatol 22(6):885–891

    Article  PubMed  CAS  Google Scholar 

  17. Choi ST, Lee HW, Song JS, Lee SK, Park YB (2014) Analysis of rheumatoid factor according to various hepatitis B virus infectious statuses. Clin Exp Rheumatol 32(2):168–173

    PubMed  CAS  Google Scholar 

  18. Skare TL, Silva MB, Holler AP, Chavez PA (2009) Protective role of rheumatoid factor in lupus nephritis. Clin Exp Rheumatol 27(5):895

    PubMed  CAS  Google Scholar 

  19. Reininger L, Berney T, Shibata T, Spertini F, Merino R, Izui S (1990) Cryoglobulinemia induced by a murine IgG3 rheumatoid factor: skin vasculitis and glomerulonephritis arise from distinct pathogenic mechanisms. Proc Natl Acad Sci U S A 87(24):10038–10042

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. Ullman S, Høier-Madsen M, Halberg P, Jans H, Sylvest J (1979) Deposits of immunoglobulins and complement in skin of patients with rheumatoid arthritis. Influence of anti-rheumatic treatment. Scand J Rheumatol 8(2):119–123

    Article  PubMed  CAS  Google Scholar 

  21. Julian BA, Czerkinsky C, Russell MW, Galla JH, Koopman WJ, Mestecky J et al (1987) Striking elevation of serum IgA, IgA-containing immune complexes, and IgA rheumatoid factor in clinically silent dermatitis herpetiformis. Am J Kidney Dis 10(5):378–384

    Article  PubMed  CAS  Google Scholar 

  22. Kudou M, Yasuba H, Kobayashi Y, Hamada K, Kita H (2006) Correlation between rheumatoid factor and peripheral eosinophil count in chronic eosinophilic pneumonia. Respirology 11(6):830–832

    Article  PubMed  Google Scholar 

  23. Boudou L, Alexandre C, Thomas T, Pallot-Prade B (2010) Chronic eosinophilic pneumonia (Carrington’s disease) and rheumatoid arthritis. Joint Bone Spine 77(5):477–480

    Article  PubMed  Google Scholar 

  24. Howard TW, Iannini MJ, Burge JJ, Davis JS 4th (1991) Rheumatoid factor, cryoglobulinemia, anti-DNA, and renal disease in patients with systemic lupus erythematosus. J Rheumatol 18(6):826–830

    PubMed  CAS  Google Scholar 

  25. Tarkowski A, Westberg G (1987) Rheumatoid factor isotypes and renal disease in systemic lupus erythematosus. Scand J Rheumatol 16(5):309–312

    Article  PubMed  CAS  Google Scholar 

  26. Gordon C, Jayne D, Pusey C, Adu D, Amoura Z, Aringer M et al (2009) European consensus statement on the terminology used in the management of lupus glomerulonephritis. Lupus 18(3):257–263

    Article  PubMed  CAS  Google Scholar 

  27. Jennette JC, Falk RJ, Hu P, Xiao H (2013) Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Annu Rev Pathol 8:139–160

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sang-Won Lee.

Ethics declarations

This study was approved by the institutional Review Board of Severance Hospital (4-2016-0901).

Disclosures

None.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moon, JS., Lee, D.DH., Park, YB. et al. Rheumatoid factor false positivity in patients with ANCA-associated vasculitis not having medical conditions producing rheumatoid factor. Clin Rheumatol 37, 2771–2779 (2018). https://doi.org/10.1007/s10067-017-3902-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-017-3902-4

Keywords

Navigation